Quality of Life in Leprosy Patient with Neuropathic Pain in Donorojo Hospital


  • Andy Faisal Diponegoro University
  • Muslimin Muslimin Diponegoro University
  • Yulian Ludovicus Aryoko Widodo S. Diponegoro University
  • Renni Yuniati Diponegoro University


Quality of Life, Leprosy, Activity Limitation, Neuropathic Pain


Background Leprosy disease in the community is usually mistaken as a cursed disease. Leprosy disease is a chronic granulomatous infection caused by Mycobacterium leprae. Quality of life in leprosy patients with neuropathic pain in every region is varied.Objective To determine the quality of life in leprosy patients with neuropathic pain by using the SALSA Scale and VAS.Methods The research used Analytic observational with a cross-sectional design and an interview technic. 37 subjects had leprosy with neuropathic pain at Donorojo Hospital. These subjects age from 19 until 59 and had neuropathic pain caused by leprosy disease. Results SALSA score explains that 62.2% of the research subject has limitation activity and has a correlation with leprosy disease with p 0.012. There is no correlation between VAS score and leprosy disease with p 0.034. SALSA score and VAS score in this research explain there is no correlation with p 0.458. The number of other medical conditions with limitation activity has a correlation score of 0.870 which has a very good correlation power. The number of used tools with limitation activity has a correlation score of 0.716 which has a good correlation power.Conclusions There is activity limitation in leprosy patients with neuropathic pain at Donorojo Hospital Jepara District. The other aspect that affect activity limitation is the number of other medical conditions. Multibacillary type has heavier limitation than a Paucibacillary type. 

Author Biographies

Andy Faisal, Diponegoro University

Undergraduate of Medicine, Faculty of Medicine, Diponegoro University

Muslimin Muslimin, Diponegoro University

Department of Dermatology, Faculty of Medicine, Diponegoro University

Yulian Ludovicus Aryoko Widodo S., Diponegoro University

Department of Biology of Medicine and Biochemistry, Faculty of Medicine, Diponegoro University

Renni Yuniati, Diponegoro University

Department of Dermatology, Faculty of Medicine, Diponegoro University


Lee D, Rea T, Modlin R. Leprosy. In: Goldsmith LA, Kats SI, Gilchreest BA, Paller AS, Leffell DJ, Wolff K, eds. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2011:6249.

Lockwood DNJ. Leprosy. In: Chalmers R, Barker J, Griffiths C, Bleiker T, Creamer D, eds. Rook’s Textbook of Dermatology. 9th ed. West Sussex: Wiley Blackwell; 2016:4696.

Wisnu IM, Sjamsoe-Daili E, Menaldi SL. Kusta. In: Ilmu Penyakit Kulit Dan Kelamin. 7th ed. Jakarta: Badan Penerbit FKUI; 2015:544.

Indonesia KKR. Profil Kesehatan Indonesia Tahun 2017. Jakarta; 2018. doi:10.1002/qj

James WD, Berger TG, Elston DM, Neuhaus IM. Andrews’ Diseases of the Skin Clinical Dermatology. 12th ed. Philadelphia: Elsevier Ltd; 2016.

Jain S. Dermatology: Illustrated Study Guide and Comprehensive Board Review. 2nd ed. (Jain S, ed.). Cham: Springer; 2017.

Narang T, Kumar B. Leprosy in Children. Indian J Paediatr Dermatology. 2019;20:12-24. doi:10.4103/ijpd.IJPD

Sehgal VN. Leprosy revisited. Clin Dermatol Res Ther. 2018;2(1):118. doi:10.4045/tidsskr.12.1184

Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis. 2006;6(6):350-360. doi:10.1016/S1473-3099(06)70493-5

World Health Organization. Classification of leprosy. https://www.who.int/lep/classification/en/. Accessed March 17, 2019.

World Health Organization. Leprosy elimination. https://www.who.int/lep/epidemiology/en/. Accessed March 17, 2019.

World Health Organization. Leprosy. http://apps.who.int/neglected_diseases/ntddata/leprosy/leprosy.html. Accessed March 17, 2019.

Indonesia KKR. Hapuskan Stigma dan Diskriminasi Terhadap Kusta. 2018:12.

Eyanoer PC. Social acceptance and quality of life of leprosy patient. IOP Conf Ser Earth Environ Sci. 2018;125:1-5. doi:10.1088/1755-1315/125/1/012100

Slamet ES, Sukandar H, Gondodiputro S. Faktor-Faktor yang Mempengaruhi Qualiy Of Life Orang yang Pernah Mengalami Kusta di Kabupaten Cirebon. Maj Kedokt Bandung. 2014:1-19.

Leite IF, Arruda AJCG de, Vasconcelos DIB de, Santana SC de, Chianca KSV. The Quality of Life of Patients with Chronic Leprosy. Jounal Nurs UFPE. 2017;9(6):8165-8171. doi:10.5205/reuol.7585-66362-1-ED.0906201503

Joseph GA, Sundar Rao PSS. Impact of leprosy on the quality of life. Bull World Health Organ. 1999;77(6):515-517.

The WHOQOL Group. WHOQOL-BREF. Introduction, Administration, Scoring, and Generic Version of The Assessment. 1996;(December).

Santos VS, Oliveira LS, Castro FDN, et al. Functional activity limitation and quality of life of leprosy cases in an endemic area in Northeastern Brazil. PLoS Negl Trop Dis. 2015;9(7):1-8. doi:10.1371/journal.pntd.0003900

SALSA. SALSA Scale (Screening Activity Limitation and Safety Awareness). Apeldoorn: The SALSA Collaborative Study Group; 2010.

Videler AJ, Beelen A, Nollet F. Manual dexterity and related functional limitations in hereditary motor and sensory neuropathy. An explorative study. Disabil Rehabil. 2008;30(8):634-638. doi:10.1080/09638280701400755

Shafrin J, Sullivan J, Goldman DP, Gill TM. The association between observed mobility and quality of life in the near elderly. PLoS One. 2017;12(8):e0182920-e0182920. doi:10.1371/journal.pone.0182920

Ofeibea Amedo A, Adade S, Yaa Koomson N, Appenteng Osae E. Influence of Visual Impairment on the Quality of Life: a Survey of Patients Reporting At the Low Vision Centre of the Eastern Regional Hospital of Ghana. J Ophthalmic Sci. 2016;1(3):1-13. doi:10.14302/issn.2470-0436.jos-16-940

Kessing D, Denollet J, Widdershoven J, Kupper N. Self-care and health-related quality of life in chronic heart failure: A longitudinal analysis. Eur J Cardiovasc Nurs. 2017;16(7):605-613. doi:10.1177/1474515117702021

Takeda K, Sawamura S, Tamai H, Sekiyama H, Hanaoka K. Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation. Anesthesiology. 2005;103(4):837-844. doi:10.1097/00000542-200510000-00023

Yamamoto D, Iwase S, Yoshida H, et al. Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer - Japan Breast Cancer Research Network (JBCRN) 02-1 trial. Anticancer Res. 2011;31(10):3567-3571.

FDA. Mobic® (Meloxicam).; 2005. https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020938s013,015,021530s001,003lbl.pdf.

Bjornsdottir S V, Jonsson SH, Valdimarsdottir UA. Functional limitations and physical symptoms of individuals with chronic pain. Scand J Rheumatol. 2013;42(1):59-70. doi:10.3109/03009742.2012.697916

Elfving B, Lund I, C LB, Bostrom C. Ratings of pain and activity limitation on the visual analogue scale and global impression of change in multimodal rehabilitation of back pain - analyses at group and individual level. Disabil Rehabil. 2016;38(22):2206-2216. doi:10.3109/09638288.2015.1116618

Brandsma JW, Van Brakel WH. WHO disability grading: Operational definitions. Lepr Rev. 2003;74(4):366-373.

Kementerian Kesehatan Republik Indonesia. Temukan Kusta Sejak Dini: Tidak Ada Kecacatan, Tidak Ada Stigma.

World Health Organization. Disabilities. https://www.who.int/topics/disabilities/en/. Accessed April 10, 2019.

Caro CC, Costa JD, Cezar da Cruz DM. The use of mobility assistive devices and the functional independence in stroke patients. Brazilian J Occup Ther. 2018;26(3):558-568. doi:10.4322/2526-8910.ctoAO1117

Horowitz A, Brennan M, Reinhardt JP, Macmillan T. The impact of assistive device use on disability and depression among older adults with age-related vision impairments. J Gerontol B Psychol Sci Soc Sci. 2006;61(5):S274-80. doi:10.1093/geronb/61.5.s274

Parette P, Scherer M. Assistive technology use and stigma. Educ Train Dev Disabil. 2004;39(3):217-226.

Maia FB, Teixeira ER, Silva GV, Gomes MK. The Use of Assistive Technology to Promote Care of the Self and Social Inclusion in Patients with Sequels of Leprosy. PLoS Negl Trop Dis. 2016;10(4):e0004644. https://doi.org/10.1371/journal.pntd.0004644.

Walsh JE. The impact of assistive technology device use on the participation levels and living arrangement decisions of older adults. Diss Abstr Int Sect A Humanit Soc Sci. 2015. http://ezaccess.libraries.psu.edu/login?url=https://search.proquest.com/docview/1692323001?accountid=13158%0Ahttp://sk8es4mc2l.search.serialssolutions.com?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&rfr_id=info:sid/PsycINFO+&rft_val_fmt=info:ofi/fmt:ke.






Original Articles